Search for Clinical Trial Results
Lambert-Eaton Myasthenic Syndrome - 22 Studies Found
Status | Study |
Available |
Study Name: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome Condition:
|
Available |
Study Name: 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM) Condition:
|
Available |
Study Name: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients Condition:
|
Recruiting |
Study Name: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes Condition: Myasthenic Syndromes, Congenital Date: 2015-09-24 Interventions:
|
Available |
Study Name: Treatment Use of 3,4-Diaminopyridine Condition:
|
Completed |
Study Name: Pregnancy Outcomes in Congenital Myasthenie Syndrome Condition: Congenital Myasthenic Syndrome Date: 2011-11-16 |
Completed |
Study Name: Ephedrine for the Treatment of Congenital Myasthenia Condition: Myasthenic Syndromes, Congenital Date: 2007-10-07 Interventions: Drug: Ephedrine |
Enrolling by invitation |
Study Name: Controlled Trial of 3,4-Diaminopyridine (3-4DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS) Condition: Muscle Weakness Date: 2014-03-14 Interventions: Drug: 3-4 Diaminopyridine Other Name: 3-4 DAP |
Recruiting |
Study Name: National Registry for Egyptian Pediatric Neuromuscular Diseases Condition:
|